• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Urinary System Drugs Endocrine System Other
  • Pharmaceutical IntermediatesPharmaceutical intermediates Heterocyclic Compound OLED material intermediate Diphenylamine intermediates Nutritional Supplements Pharmaceutical raw materials
  • Medicine ExcipientsFiller Solubilizers Coating material Disintegrant Excipient Iubricant Other
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Gastrointestinal Drugs Disinfectant Anthelmintics Antiviral drugs Sow health care Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl

    • Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl
    • Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl storehouse
    • Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl quality testing
    • Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl quality testing
    • Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl certificate

    Product Overview:

    Tetracaine hydrochloride is a highly effective local anesthetic that can block nerve function reversibly. It is used in infiltration anesthesia, nerve block anesthesia, epidural anesthesia, etc. Compared with procaine, tetracaine has remarkable local anesthetic effect and has been widely used in clinic. It is found that the synthesis of p-butylaminobenzoic acid is the key step in the synthesis of tetracaine hydrochloride, which always has the disadvantages of unstable raw materials or low yield. Scientists have improved and improved this, in 1981 proposed to synthesize p-butylaminobenzoic acid by alkylation of p-aminobenzoic acid with 1-bromobutane, but because it can not avoid the generation of double butylated by-products, and the nature of the raw material itself is unstable, making this route is not suitable for industrial production.

    Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl Attributes

    Tetracaine HCl Raw Powder Liensinine

    CAS:136-47-0

    MF:C15H25ClN2O2

    Tetracaine HCl

    MW:300.82

    EINECS:205-248-5

    Specification​: 99% min Tetracaine HCl

    Sample:Tetracaine HCl Powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Henrikang

    Appearance:white

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Tetracaine hydrochloride raw Powder CAS 2586-96-1 Tetracaine HCl Details

    Tetracaine HCl Usage and Synthesis.

    Tetracaine hydrochloride is a kind of long-acting ester local anesthetic, which has the characteristics of strong penetration of mucosa and is suitable for surface anesthesia, and is often used in ophthalmology. After injection, the anesthetic effect appears slow (about 10 minutes), the post-absorption metabolism is also slow, and the local anesthesia time is up to 3 IJ, H,-J. Around. There were no adverse reactions such as vasoconstriction, dilated pupil and corneal injury after tetracaine hydrochloride, and the local anesthetic effect and toxicity were about 10 times greater than that of procaine. It is mainly used for surface anesthesia of the mucous membranes of the eyes, nose and throat, and rarely used for conduction anesthesia and epidural anesthesia. It is generally not used for infiltration anesthesia due to high toxicity.

    Tetracaine HCl powder

    Uses of Tetracaine HCl.

    Tetracaine hydrochloride is used for mucosal surface anesthesia, conduction anesthesia, epidural anesthesia and subarachnoid anesthesia. It is used for ophthalmic surface anesthesia without constricting blood vessels, damaging corneal epithelium and increasing intraocular pressure.

    Tetracaine HCl

    Drug interaction of Tetracaine HCl.

    1. This drug can enhance the nerve blocking effect of cisatracurium, and the dosage of the latter should be reduced when combined.

    2. In combination with adrenaline, blood vessels can be constricted, blood flow is reduced, drug absorption is slowed down, and the duration of action is prolonged. However, they are not suitable for patients with heart disease, hypertension, hyperthyroidism and peripheral vascular disease.

    3. Hyaluronidase can effectively increase the diffusion of this drug, accelerate the effect of anesthesia, reduce local swelling, and prevent the formation of hematoma, however, hyaluronidase can also accelerate the absorption of this drug, resulting in increased toxic reactions of this drug.

    4. This drug is a derivative of p-aminobenzoic acid (PABA), and sulfonamides play an antibacterial role by inhibiting PABA of bacteria. When this drug is combined with sulfonamides, the antibacterial effect of the latter will be inhibited, so the two are not suitable for use.

    5. This medicine is acidic and should not be mixed with alkaline liquid. Even if it is an acidic drug, the dissociation value of the drug can be affected due to the difference in pH, so that the effect is reduced, or the onset time is delayed.

    6. Iodine preparation can cause the precipitation of this drug, so the injection site of this drug can not use iodine.

    Product Method of Tetracaine HCl.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,